We are live on
!
Find out more
IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
1-Year Est. Return
10.79%
This Fund
S&P 500
This Quarter
Est. Return
+29.89%
1 Year Est. Return
-10.79%
3 Year Est. Return
-29.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$277M
AUM Growth
+$73M
(+36%)
Cap. Flow
+$37.5M
Cap. Flow
% of AUM
13.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
+$32.2M |
| 2 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
+$5.38M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 74.62% |
| 2 | Technology | 25.05% |
| 3 | Consumer Staples | 0.24% |
| 4 | Consumer Discretionary | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $80M | 28.9% |
2,768,586
+178,571
| +7% | +$5.38M |
|
2
Yext
YEXT
$522M
| $68.9M | 24.89% |
4,146,784
| – | – |
|
3
Arcus Biosciences
RCUS
$3.53B
| $45.6M | 16.47% |
1,842,077
| – | – |
|
|
4
Oric Pharmaceuticals
ORIC
$1.08B
| $34M | 12.28% |
+1,007,576
| New | +$32.2M |
|
5
NovoCure
NVCR
$1.86B
| $27.9M | 10.09% |
470,884
| – | – |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $19M | 6.87% |
219,000
| – | – |
|
7
Chegg
CHGG
$94.6M
| $664K | 0.24% |
9,868
| – | – |
|
8
Sunrun
RUN
$2.96B
| $427K | 0.15% |
21,657
| – | – |
|
9
Alibaba
BABA
$269B
| $261K | 0.09% |
1,211
| – | – |
|
Similar funds
ETIA
CC
OAMA
FWM
GIM
YSP
EL
CH